文献速递眼整形与眼眶

羟基磷灰石眶内植入物缩小的病例系列

Case series of shrinking hydroxyapatite orbital implants.
PubMed 文献 · Br J Ophthalmol · 2021-05-26

该病例系列回顾了2011至2015年间在新西兰但尼丁医院取出的6例骨源性羟基磷灰石眶内植入物,其中4例体积小于原始尺寸;所有标本均有纤维血管浸润,3例见慢性炎症细胞,1例见破骨细胞活性。结论提示骨源性羟基磷灰石植入物可能缩小,可能与破骨细胞活性有关,术者选择植入物类型时需考虑此情况。

要点

  • 骨源性羟基磷灰石眶内植入物可能发生体积缩小。
  • 取出的6例植入物中4例小于原始尺寸。
  • 组织学多见纤维血管浸润,部分见慢性炎症或破骨细胞活性。

核心结论

  • 骨源性羟基磷灰石眶内植入物可发生缩小,可能与破骨细胞活性有关。
  • 术者在眼球摘除或内容物剜除后选择植入物类型时应考虑植入物缩小的情况。

研究设计与样本

  • 回顾性病例系列,检索新西兰但尼丁医院2011至2015年手术室记录,纳入取出羟基磷灰石眶内植入物的患者,记录原始与取出时尺寸及组织学结果并复习病历。

主要发现

  • 共6例患者取出羟基磷灰石眶内植入物。
  • 6例中4例植入物小于原始尺寸。
  • 所有标本均有纤维血管浸润,3例见慢性炎症细胞,1例见破骨细胞活性。

临床怎么用

  • 对骨源性羟基磷灰石眶内植入物术后患者,应关注眶容积丢失及植入物缩小的可能。
  • 眼球摘除或内容物剜除选择植入物时,需将骨源性羟基磷灰石可能缩小纳入决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: An orbital implant is used after enucleation or evisceration surgery to replace the volume lost and to aid in prosthesis fitting and movement. Different materials have been used through the years. The authors noted that with bone-derived hydroxyapatite orbital implants, some patients lose their orbital volume. METHODS: The operating theatre record was searched to find patients who had their hydroxyapatite orbital implant removed at Dunedin Hospital, New Zealand, between 2011 and 2015. The original implant size and size at removal were noted. Histological results were noted. Medical notes were reviewed. RESULTS: A total of six patients had hydroxyapatite orbital implants removed during this time. Four patients had implants that were smaller than their original sizes. All specimens had fibrovascular infiltration noted, three had chronic inflammatory cells and one had osteoclastic activity. CONCLUSIONS: Bone-derived hydroxyapatite orbital implants can reduce in size, and this may occur due to osteoclastic activity. The surgeon must consider this scenario when choosing the type of implant to be used after enucleation or evisceration.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Han LS, Keillor RB, Weatherhead RG, et al. Case series of shrinking hydroxyapatite orbital implants. Br J Ophthalmol. 2021. PMID: 34039563. doi:10.1136/bjophthalmol-2021-319397

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。